Pixium Vision S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
15.14 M |
Public Float |
- |
Pixium Vision S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.69 |
Market Cap |
EUR29.55 M |
Shares Outstanding |
20.81 M |
Public Float |
9.19 M |
Address |
74, rue du Faubourg Saint-Antoine Paris Ile-de-France 75012 France |
Employees | - |
Website | http://www.pixium-vision.com |
Updated | 07/08/2019 |
Pixium Vision SA engages in the development of innovative retinal implant systems specializing in sensory neuromodulation. Its products include Intelligent Retinal Implant Systems and PRIMA system. The IRIS treats patients who have lost their sight through degenerative conditions of the eye such as retinitis pigmentosa, other retinal dystrophies or age-related macular degeneration. |